Anorexia Nervosa: Neurobiology, Diagnostic Criteria, Medical Complications, and Evidence-Based Treatment Planning

Anorexia nervosa (AN) is a severe, potentially life-threatening eating disorder characterized by persistent restriction of energy intake, intense fear of gaining weight or persistent behavior that interferes with weight gain, and disturbance in the way one’s body weight or shape is experienced. Clinically, AN can present across subtypes (restricting type and binge-eating/purging type), but the central theme is maladaptive regulation of food intake and body image-related cognition.

From a neurobiological perspective, AN involves dysregulation of appetite and reward pathways. Hypothalamic signaling that integrates leptin, ghrelin, and other metabolic cues can become chronically altered, reinforcing restrictive eating behaviors. Dysregulated dopamine-mediated reward processing and altered serotonergic function may contribute to heightened anxiety around eating and a reduced rewarding value of food. Stress-response systems, including corticotropin-releasing factor (CRF) pathways, appear sensitized; this can intensify avoidance of eating and perpetuate conditioned fear responses to meals.

Cognitive and behavioral mechanisms are central to maintenance. Overvaluation of shape and weight drives persistent compensatory behaviors and rigid food rules, often accompanied by cognitive distortions (e.g., catastrophizing weight gain consequences). Cognitive rigidity, harm avoidance, and perfectionism traits are frequently observed, and these features can interact with social reinforcement or criticism, sustaining restrictive patterns. Interoceptive deficits—reduced ability to accurately perceive hunger, fullness, and emotional states—may further weaken adaptive decision-making around eating.

Diagnostic assessment follows established criteria requiring careful evaluation of symptom duration, severity, and functional impact. Key medical and psychiatric considerations include measurement of BMI or weight history, vital signs, menstrual status where relevant, and screening for comorbidities such as major depressive disorder, anxiety disorders, obsessive-compulsive symptoms, and substance use. Differential diagnosis is critical: AN must be distinguished from avoidant/restrictive food intake disorder, gastrointestinal disease, endocrine disorders (e.g., hyperthyroidism, adrenal insufficiency), and other psychiatric or neurologic conditions that can affect appetite and weight.

Medical complications are a defining risk in AN. Starvation leads to multi-system effects including bradycardia, hypotension, orthostatic intolerance, arrhythmias, electrolyte abnormalities (notably hypokalemia, hypophosphatemia, and metabolic derangements), and impaired thermoregulation. Hematologic abnormalities (e.g., anemia, leukopenia) may occur due to nutritional deficiency. Bone health is compromised through low estrogen and altered bone remodeling, producing osteopenia and increased fracture risk. Gastrointestinal motility slows, causing constipation and bloating. If refeeding occurs after prolonged malnutrition, refeeding syndrome—characterized by rapid shifts in electrolytes such as phosphate—can cause respiratory failure, cardiac dysfunction, and death. Therefore, refeeding requires structured monitoring and gradual nutritional escalation.

Treatment is multidisciplinary and phase-based, aiming to restore nutrition, normalize eating patterns, address distorted cognitions, and manage comorbid psychopathology. Psychotherapy with proven benefit includes family-based treatment (FBT) for adolescents, which mobilizes caregivers to support weight restoration while maintaining appropriate boundaries. Cognitive behavioral therapy tailored for eating disorders (CBT-E) can address maintaining mechanisms (overvaluation of weight/shape, dietary restraint, and cognitive rigidity) in adolescents and adults. For adults, structured psychotherapy and relapse prevention strategies are typically combined with nutritional rehabilitation and risk management.

Pharmacotherapy is not a standalone treatment for the core restrictive behavior, but medications may be used to treat comorbid anxiety or depression. Medication choices must consider nutritional status, drug metabolism changes in malnutrition, and potential interactions with electrolyte abnormalities that can affect cardiac conduction. No medication currently substitutes for weight restoration; however, adjunctive pharmacologic management may improve symptom burden and facilitate engagement in therapy.

Nutritional rehabilitation should be carefully designed, typically beginning with a structured plan that achieves adequate caloric intake while monitoring for refeeding risk. Refeeding protocols incorporate baseline labs (including phosphate, magnesium, potassium), cardiac assessment when indicated, and frequent follow-up. Medical stabilization may require inpatient or partial hospitalization when there is bradycardia, orthostatic hypotension, syncope, significant electrolyte disturbance, dehydration, or inability to maintain safe intake.

Prognosis depends on early recognition, severity at presentation, comorbidity burden, and treatment adherence. Some individuals experience full recovery, while others have chronic or relapsing courses. Early intervention is associated with improved outcomes.

Source: @icryduringsex0